Greenfield Savings Bank Sells 315 Shares of Exelon Co. (NASDAQ:EXC)

Greenfield Savings Bank lowered its stake in shares of Exelon Co. (NASDAQ:EXCFree Report) by 5.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,474 shares of the company’s stock after selling 315 shares during the quarter. Greenfield Savings Bank’s holdings in Exelon were worth $206,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. American National Bank & Trust boosted its position in shares of Exelon by 178.8% during the 3rd quarter. American National Bank & Trust now owns 697 shares of the company’s stock worth $28,000 after acquiring an additional 447 shares in the last quarter. Abound Wealth Management increased its stake in shares of Exelon by 502.7% in the 2nd quarter. Abound Wealth Management now owns 892 shares of the company’s stock valued at $31,000 after purchasing an additional 744 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Exelon during the 3rd quarter worth $32,000. Versant Capital Management Inc lifted its position in shares of Exelon by 56.7% during the 4th quarter. Versant Capital Management Inc now owns 1,047 shares of the company’s stock worth $39,000 after buying an additional 379 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC acquired a new stake in Exelon in the second quarter valued at about $41,000. 80.92% of the stock is owned by institutional investors and hedge funds.

Exelon Price Performance

Shares of NASDAQ:EXC opened at $37.56 on Tuesday. Exelon Co. has a twelve month low of $33.35 and a twelve month high of $41.19. The stock’s 50 day moving average is $37.97 and its 200-day moving average is $38.12. The company has a quick ratio of 0.97, a current ratio of 1.09 and a debt-to-equity ratio of 1.66. The firm has a market capitalization of $37.74 billion, a price-to-earnings ratio of 15.46, a PEG ratio of 2.63 and a beta of 0.55.

Exelon (NASDAQ:EXCGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.04. The firm had revenue of $6.15 billion during the quarter, compared to analysts’ expectations of $5.85 billion. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The business’s revenue was up 2.9% on a year-over-year basis. During the same period last year, the company earned $0.67 earnings per share. Sell-side analysts forecast that Exelon Co. will post 2.45 EPS for the current fiscal year.

Exelon Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Monday, November 11th were paid a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a yield of 4.05%. The ex-dividend date of this dividend was Friday, November 8th. Exelon’s dividend payout ratio (DPR) is presently 62.55%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on EXC shares. Jefferies Financial Group began coverage on shares of Exelon in a report on Thursday, September 19th. They issued a “buy” rating and a $46.00 target price for the company. Scotiabank raised their target price on shares of Exelon from $40.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, December 12th. Barclays upped their price target on shares of Exelon from $41.00 to $44.00 and gave the stock an “overweight” rating in a report on Tuesday, October 15th. UBS Group boosted their price objective on Exelon from $40.00 to $43.00 and gave the stock a “neutral” rating in a research report on Friday, September 20th. Finally, Morgan Stanley dropped their target price on Exelon from $46.00 to $44.00 and set an “equal weight” rating for the company in a research report on Friday, November 22nd. Six research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Exelon currently has a consensus rating of “Hold” and an average price target of $42.38.

Check Out Our Latest Stock Report on EXC

Exelon Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Recommended Stories

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.